Michael Petusky

Stock Analyst at Barrington Research

(0)
# 4744
Out of 5,441 analysts
214
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
VRME VerifyMe
Maintains: Outperform
2 2
0.78 92.31% 10 Aug 14, 2025
SRDX Surmodics
Reiterates: Market Perform
n/a
n/a n/a 7 Aug 11, 2025
XRAY Dentsply Sirona
Maintains: Outperform
21 18
12.52 43.77% 21 Aug 8, 2025
USPH US Physical Therapy
Maintains: Outperform
98 103
86.78 18.69% 24 Aug 8, 2025
HAE Haemonetics
Maintains: Outperform
95 86
52.47 63.9% 25 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
95
92.59 2.6% 11 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
86 78
66.11 17.99% 15 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
103 103
84.05 22.55% 21 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
19 15
8.23 82.26% 18 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
38 38
27.85 36.45% 16 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
16
12.95 23.55% 1 Jun 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 15 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
3 3
1.29 74.42% 12 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 12
8.76 36.99% 6 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
10.28 36.19% 1 Jun 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 11, 2016